"The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone (GCTB), a rare and usually non-cancerous tumor.
GCTB generally occurs in a"...
(Generic versions may still be available.)
Mono-Vacc Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Mono-Vacc Test (O.T.) is a multiple puncture intradermal test for the detection of tuberculin sensitivity in high-risk children. The brand name of this medication is discontinued, but generic versions may be available. Common side effects include blisters, ulcers, or dead tissue, pain, or itching at the test site.
The activity per Mono-Vacc Test is comparable to or greater than 5 tuberculin units (5 TU) administrated by the Mantoux method. Mono-Vacc Test may interact with corticosteroids or immunosuppressive drugs. Tell your doctor all medications and supplements you use and all vaccines you recently received. During pregnancy, Mono-Vacc Test should be administered only if prescribed. Tell your doctor if you are pregnant before receiving this test. Consult your doctor before breastfeeding.
Our Mono-Vacc Test (O.T.) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Mono-Vacc FDA Prescribing Information: Side Effects
Additional Mono-Vacc Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.